Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Urologic Neoplasms
30. May 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 8932
Articles 1 - 20 / 178628
Bayesian Evaluation of Treatment Effect of Avelumab Plus Axitinib for Advanced Renal Cell Carcinoma.
Cancer Med
Fukuokaya W, Mori K, Yanagisawa T, Ito K, Imai Y, Urabe F, Rajwa P, Shariat SF, Kimura T, Hirakawa A.
PMID: 42216439 [PubMed - indexed for MEDLINE]
Top advances of the year: Radiopharmaceutical therapy for prostate cancer.
Cancer
Marulanda-Corzo V, Coraci S, Kakkar P, Okobi TJ, Huicochea-Castellanos S, Osborne JR, Tagawa ST.
PMID: 42216431 [PubMed - indexed for MEDLINE]
Association of DNA damage repair related genes with prostate cancer: A multi-omics Mendelian Randomization analysis.
Medicine (Baltimore)
Xie H, Ban C, Su Z, Huang Q, Tang H, Cheng Z, Liao T, Liao K, Yi X.
PMID: 42216412 [PubMed - indexed for MEDLINE]
HyperSight(TM)-CBCT based monitoring of sarcopenia during definitive radiotherapy of prostate cancer: a longitudinal feasibility study.
Radiat Oncol
Siefert V, V Bettenhausen J, Bicu AS, Schmidt R, Willam M, Eckl M, Stieler F, Ehmann M, Buergy D, Fleckenstein J, Beuthien-Baumann B, Schlemmer HP, Froelich MF, Schoenberg SO, Giordano FA, Boda-Heggemann J, Dreher C.
PMID: 42216209 [PubMed - indexed for MEDLINE]
MSTM-Net: a two-stage prostate cancer segmentation network based on swin-transformer-mamba architecture.
BMC Med Imaging
Chen J, Liu X, Wang S, Ji W.
PMID: 42215932 [PubMed - as supplied by publisher]
Trends and etiological profile of kidney cancer in China from 1990 to 2023: an analysis of modifiable risk factors and prevention implications using GBD 2023 estimates.
Int J Clin Oncol
Ye Z, Wu H, Zhang C, Wang R, Deng X, Hu E, Wang Z, Gao B.
PMID: 42215789 [PubMed - as supplied by publisher]
Development and validation of a noninvasive machine learning model using urinary extracellular vesicle physical parameters for prostate cancer diagnosis.
Sci Rep
Jiang K, Pan D, Yu J, Cai W, Zhang B, Wang Z, Lu Y, Wang D, Li X, Zheng D, Wang M, Wang F, Chen J.
PMID: 42215604 [PubMed - as supplied by publisher]
Unmet Treatment Need and Challenges Associated with Comparative Evidence Generation in BCG-unresponsive Non-muscle-invasive Bladder Cancer: An Expert Consensus.
Eur Urol Oncol
Gontero P, Perry R, Bridge D, Delattre DD, Vosgerau S, Wyn R, Stone M, Babjuk M.
PMID: 42215335 [PubMed - as supplied by publisher]
AI-MIRACLE: Artificial Intelligence and MultIpaRAmetric MRI Predict CLinical OutcomEs to Neoadjuvant Immunotherapy in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy.
Eur Urol Oncol
Necchi A, Brembilla G, Whiting K, Arita Y, Akin O, Apte A, Awais M, Lema-Dopico A, Paudyal R, Cosenza M, Maiorano BA, Tateo V, Cigliola A, Mercinelli C, De Cobelli F, Capanu M, Shukla-Dave A, Schwartz LH.
PMID: 42215334 [PubMed - as supplied by publisher]
Dyadic Coping and Its Influencing Factors in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy and Their Spouses: A Latent Class Analysis.
J Clin Nurs
Chen H, Li Y, He H, Lin H, Song X, Li K.
PMID: 42215288 [PubMed - as supplied by publisher]
Emerging role of urinary biomarkers in bladder cancer diagnosis and prognosis.
Urol Oncol
Paleru G, Singathala GS, Kural S, Kumar L.
PMID: 42214859 [PubMed - as supplied by publisher]
Clinical Manifestations, Tumor Associations, and Long-Term Outcomes of Anti-KLHL11 Encephalitis.
Neurol Neuroimmunol Neuroinflamm
Jin M, Brand T, Erdag Turgeon E, Havelaar AC, Van Steenhoven RW, Nagtzaam MMP, Franken SC, Abu Hassan SHB, Bastiaansen AEM, Brenner J, Sillevis Smitt PAE, de Graaff E, Veenbergen S, de Vries JM, Kerstens J, Titulaer MJ.
PMID: 42214057 [PubMed - indexed for MEDLINE]
Prostate Cancer Treatment Patterns and Inequities Among Racial Groups in Brazil's Public Health System: Insights From a 16-Year Real-World Study.
JCO Glob Oncol
Herchenhorn D, Abboud H, Freire V, Tarouquella J, Monteiro FSM, Fay AP, Freitas JLR, Mckay RR, Rose B, Carvalhal GF, Morbeck I, Maluf FC, Souza VC, Valverde D, Firmino EF, Sasse AD, Bastos D, James N.
PMID: 42214044 [PubMed - indexed for MEDLINE]
Genitourinary Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2025: Advances in Renal Cell Carcinoma and Muscle-invasive Bladder Cancer.
Oncol Res Treat
Zhang XW, Schlack K, Hartmann A, Steiner T, Siska PJ.
PMID: 42213621 [PubMed - as supplied by publisher]
Letter to the Editor: Diagnostic performance of the clear cell likelihood score integrated with cystic degeneration or necrosis on MR imaging for identifying clear cell renal cell carcinoma in cT1 solid renal masses.
Insights Imaging
Hekimsoy .
PMID: 42213342 [PubMed]
Reply to the Letter to the Editor: Diagnostic performance of the clear cell likelihood score integrated with cystic degeneration or necrosis on MR imaging for identifying clear cell renal cell carcinoma in cT1 solid renal masses.
Insights Imaging
Ning X, Wang H.
PMID: 42213314 [PubMed]
Comparative efficacy and safety of open, laparoscopic, and robot-assisted radical cystectomy: a systematic review and network meta-analysis.
J Robot Surg
Zhao L, Chen HM, Li YT, Zhang T, Yang JW, Wang L, Li XR, Shao LC, Chen SY.
PMID: 42213216 [PubMed - indexed for MEDLINE]
Comparison of PET imaging of [18F]F-FAPI and [18F]F-FDG for diagnosis of suspected lymph node metastases in penile squamous cell carcinoma: a prospective pilot study.
Eur J Nucl Med Mol Imaging
Ouyang W, Tong X, Hou W, Zhou C, Fu H, Liu J, Wang Q, Liu Z, Yao K, Li X, Zhao M, Wang L.
PMID: 42213124 [PubMed - as supplied by publisher]
Long-Term Clinical Outcomes of Advanced Germ Cell Tumors: Experience From 105 Patients Over 20 Years.
Int J Urol
Yamashita R, Sakura Y, Sugino T, Notsu A, Matsuo T, Hayashi Y, Ito K, Shinsaka H, Nakamura M, Matsuzaki M, Niwakawa M.
PMID: 42212783 [PubMed - indexed for MEDLINE]
Addition of Intravesical Recombinant BCG to Perioperative Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase 2 Trial SAKK 06/19.
J Clin Oncol
Cathomas R, Petrausch U, Hayoz S, Spahn M, Bubendorf L, Schäuble K, Strebel RT, Niederberger P, Stenner F, Hirschi A, Vogl U, Lorch A, Tsantoulis P, Aeppli S, Erdmann A, Maranta AF, Fankhauser C, Hötker AM, Pausch AM, Herzig P, Le Gall V, Zippelius A, Chiquet S, Rothschild SI, Rentsch CA.
PMID: 42212670 [PubMed - as supplied by publisher]
Articles 1 - 20 / 178628
Page 1 of 8932
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy